Abstract Purpose of Review This scoping review aims to evaluate the molecular mechanisms, therapeutic potential, and safety concerns of Body Protective Compound-157 (BPC-157) in the context of musculoskeletal healing
This figure, drawn from the original plasma studies following GHK-Cus identification, has become the standard reference point in the literature whenever researchers discuss the peptides relationship to aging
Yet B12 deficiency is surprisingly widespread
Moderated by Axios, panelists discussed the promise of these therapies, the risks and regulatory challenges surrounding non-FDA-approved compounded versions, and what the next phase could mean for patients, providers, policymakers, and industry
Related compounds and blends are comparisons only, not interchangeable